Xeris Biopharma Holdings Inc
XERS
Market Cap$725.06M
Close$
$2.89
44% downside
Current Fair Value
44% downsideOvervalued by 44% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $725.06 Million |
|---|---|
| Enterprise Value | $707.88 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.37 |
| Beta | 0.89 |
| Outstanding Shares | 149,092,881 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.81 |
|---|---|
| PEG | -43.98 |
| Price to Sales | 5.16 |
| Price to Book Ratio | -5.16 |
| Enterprise Value to Revenue | 3.81 |
| Enterprise Value to EBIT | -15.67 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | -1.84 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Xeris Pharmaceuticals Inc
CEO: paul Edick